MEDirect Latino Selects Datascension, Inc. to Provide Bi-Lingual Customer Intake Support for National Television Advertising Cam
01 Junio 2005 - 8:01AM
Business Wire
MEDirect Latino Inc. (OTC:MLTO), http://www.medirectlatino.org,
today, announced the selection of Datascension, Inc. Brea,
California to provide bi-lingual customer intake support for the
Company's national television advertising campaign. Datascension
International Inc. (OTC:DSEN), is a premier data solutions company,
which employs hundreds of bilingual professionals, and is rapidly
becoming one of the largest Spanish-speaking customer service
centers. "After a thorough vetting process, the Company's selection
committee chose Datascension Inc. to support our uniquely trained
and skilled bi-lingual diabetic customer care representatives,"
stated MEDirect Latino President, Ms. Debra L. Towsley.
"Datascension was chosen because of its understanding of what
MEDirect Latino is accomplishing in the Hispanic healthcare
marketplace. Initially, Datascension will process inbound calls in
support of the Company's in-house customer care representatives.
Outsourcing this bi-lingual support will allow the Company to
initiate its national advertising campaign on major
Spanish-language television networks on June 15, 2005, which is 90
days ahead of schedule." MEDirect Latino currently services
Medicare eligible customers in the United States and Puerto Rico.
The Company's training for its customer care representatives
integrates five selling methodologies, which are culturally
specific and demographically driven. Additionally, the Company
requires its pharmaceutical suppliers to provide on-going
comprehensive training on new products and services. MEDirect
Latino is the first company to develop a culturally specific,
bi-lingual, direct-to-consumer, sales program in the United States,
focused on the Medicare eligible Hispanic diabetic consumer. A free
independent corporate analysis of MEDirect Latino Inc, which
includes information on the Company's business model, products,
industry, valuation, management, and risks, and reaches an initial
short term price target of $8 per share is available at
http://www.wallstreetresources.net/pdf/fc/MLTO.pdf Also, MEDirect
Latino completed an investor conference call on Tuesday, May 17,
2005. To hear a recording of the call: -0- *T Call 1-800-977-8002
in the United States or Canada or; Call 1-404-920-6650 in the
Atlanta Area or Internationally Pin Code: Press the star key then
098756 *T About MEDirect Latino: MEDirect Latino (OTC:MLTO),
http://www.medirectlatino.org, is a rapidly growing, uniquely
positioned provider of direct-to-consumer Medicare reimbursed
medical products focused exclusively on chronic diseases afflicting
the Hispanic community in the United States and Puerto Rico.
MEDirect is the only company positioned to serve the U.S. Hispanic
healthcare market as a direct-to-consumer Medicare provider on an
authentically national level. The Company's current focus is the
distribution of products for the treatment of Type II diabetes
specifically because of its disproportionate impact and increasing
diagnosis rate within the US Hispanic population, noting an
incidence of 120% higher than among non-Hispanic whites. Type II
diabetes was also targeted because of its unique status within the
Medicare reimbursement regime and because of its high degree of
correlation to other chronic conditions such as high blood pressure
and heart disease. These other conditions represent considerable
future market potential that will allow MEDirect to efficiently
scale its model by leveraging its existing client base and
infrastructure. The current Hispanic market for MEDirect's products
is conservatively estimated at approximately $650MM in the
continental United States. The size of the opportunity is
understated by such figures as an estimated 925,000 of the over 3.1
million Hispanics in the United States over 65 eligible to receive
Medicare benefits are currently collecting these benefits with an
estimate that over 1.4 million of those Medicare-eligible Hispanics
have diabetes (implying a potential continental U.S. market for
MEDirect products of approximately $1 billion) About Datascension,
Inc.: Datascension International, Inc. (OTC:DSEN) a wholly owned
subsidiary of Datascension, Inc. a premier data solutions company
and business process outsourcing provider with operations in
California, Costa Rica and the Dominican Republic, embodies a
unique expertise in the collection, storage and processing of
marketing data. Employing hundreds of bilingual professionals, the
company is rapidly becoming one of the largest Spanish-speaking
call centers. The company's commitment to customer service, quality
and on-time project management has fostered its world-class
reputation among major market research firms and corporate market
research departments. Datascension International's management team
boasts over 30 years of successful experience in developing and
implementing client solutions. It has an extensive list of
satisfied customers (including the hospitality, entertainment, and
automotive sectors) with emphasis and commitment to absolute
customer service, quality assurance and on-time project management.
Datascension International's main facility located in Brea,
California, is the centralized location for the majority of its
services. Datascension International, which already employs
hundreds of bilingual Spanish-English speaking callers, is rapidly
becoming one of the largest Spanish-speaking phone centers. Forward
Looking Statements: Statements about the Company's future
expectations, including future revenues and earnings, and all other
statements in this press release other than historical facts are
"forward-looking statements" within the meaning of section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as the term is defined in the Private Litigation
Reform Act of 1995. The Company's actual results could differ
materially from expected results. The Company undertakes no
obligation to update forward-looking statements to reflect
subsequently occurring events or circumstances. Should events occur
which materially affect any comments made within this press
release; the Company will appropriately inform the public.
Medirect Latino (CE) (USOTC:MLTO)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Medirect Latino (CE) (USOTC:MLTO)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024